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AbstrAct
Description of a case report of Gorlin-Goltz Syndrome diagnosed in a male 
newborn who presented increased head circumference and bifid ribs. Mother and 
grandmother presented typical physical findings of the syndrome, including palmar 
pits, odontogenic cysts, and history of multiple skin cancer resections. The diagnosis 
was based on clinical findings of three relatives. A literature review is also presented.
Keywords: Gorlin-Goltz Syndrome; bifid rib; skin cancer
Case Report
Clin Biomed Res. 2014;34(3):313-317
1 Department of Pediatrics, Hospital 
de Clínicas de Porto Alegre (HCPA). 
Porto Alegre, RS, Brazil.
 
2 Medical School, Universidade 
Federal do Rio Grande do Sul 
(UFRGS). Porto Alegre, RS, Brazil. 
3 Department of Genetics, HCPA, 
Porto Alegre, RS, Brazil.
Corresponding author: 
Adrianne Rahde Bischoff 
E-mail: arahdebischoff@gmail.com
Porto Alegre, RS, Brazil.
The Gorlin-Goltz Syndrome or Nevoid Basal Cell Carcinoma Syndrome 
is a dominant autosomal genetic disorder that predisposes the emergence 
of skin neoplasia as well as other developmental abnormalities1. 
Caused by a mutation in the PTCH1 gene, its presentation is variable, 
although it has been classically described as the triad: basal cell carcinoma, 
keratocystic odontogenic tumors, and bifid ribs1. The diagnosis is clinical, if 
the patient presents two major criteria or one major criterion with two minor 
criteria; genetic testing is only necessary if those are absent2.  
Here we present a case report of a newborn evaluated at this hospital 
(HCPA) with suggestive findings of this syndrome, followed by a brief 
literature review.
Case report:
Twenty-year-old woman, 39 weeks and 6 days pregnant, spontaneously 
came to the hospital due to high blood pressure. She had no comorbidities, 
and her prenatal course had been uneventful. An obstetric morphologic 
ultrasound in the first trimester presented nuchal translucency of 5 mm. 
A cesarean was performed (fail to induce labor), with intact membranes 
and normal amniotic fluid. Male newborn, birth weight 3,685 g, Apgar 5/9, 
Capurro of 39 weeks and 5 days, appropriate for gestational age. 
The first physical examination of the newborn demonstrated a 38 cm 
head circumference (percentile>98), two bone prominences in the sternum 
and no further findings, including a normal neurologic exam. A normal 
cerebral ultrasound was performed. A chest x-ray showed structural 
alterations in the sternum and in the ribs (specially a right bifid rib – Figure 1) 
without cardiopulmonary findings. Mother and maternal grandmother were 
examined, presenting head circumference of 60.5 and 58.5 cm respectively 
(both >p98) and palmar pits in both hands. Family history showed that the 
mother had a delayed neurodevelopment during childhood and is currently 
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being treated for odontogenic cysts elsewhere; the 
grandmother has had more than one resected skin 
cancer. Based on physical findings of the newborn, 
mother and grandmother, the main diagnostic 
hypothesis was Gorlin-Goltz Syndrome. The family 
was properly informed (they were unaware of any 
genetic disease in their family). 
The patient had an excellent postnatal evolution 
and had hospital discharge with his mother a few 
days after birth, with scheduled ambulatory return 
in the genetics department of the same hospital.
Discussion
The Gorlin-Goltz Syndrome is an inherited, 
autosomal dominant, completely penetrant 
disorder with variable expressivity3. Isolated cases 
are frequent, representing up to 60% of the affected 
people, and its estimated prevalence varies among 
populations, between 1:55,600 and 1:256,000, with 
no gender difference 4,5.  
Most cases are caused by heterozygous 
mutations in the PTCH1 membrane receptor 
gene5. PTCH1 is a component of the hedgehog 
(Hh) signaling pathway, working as a receptor for 
the ligand sonic hedgehog (SHH)6. In the absence 
of the ligand, PTCH1 inhibits the expression of 
smoothened (SMO) and its signaling cascade, 
including transcription factors of the family of 
glioma-associated oncogenes (GLI). This way, 
loss-of-function mutations in PTCH1 result in 
abnormal activation of Hh signaling pathway, which 
is involved in many physiologic processes, such as 
axial, facial, and appendicular skeleton formation, 
lip fusion, and the hair follicle cycle7.  Moreover, the 
excessive activation of the Hh signaling pathway is 
associated with different types of cancer, especially 
basal cell carcinoma, and mutations in this pathway 
were identified in more than 90% of sporadic 
cases of this cancer. Mutations in PTCH2, which 
encodes a close homolog of the PTCH1 receptor, 
and SUFU, which encodes a negative regulator 
of GLI transcription factors, have been described 
in a few families with Gorlin syndrome without 
mutations in PTCH18. The clinical diagnosis is 
made in the presence of two major criteria or one 
major associated with two minor (table 1)9. This 
case presented bilateral structural alterations in the 
Figure 1: Thorax radiography - Bifid rib
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ribs, including a bifid rib, and a first-degree relative 
presenting the syndrome (as two major criteria) 
and macrocephaly (as one minor). 
Basal cell carcinoma is the main component of 
the syndrome, occurring between puberty and 35 
years of age5,9 in any part of the body, especially 
in those exposed to sunlight. Other cutaneous 
manifestations include sebaceous cysts and 
palmar and plantar pits, that develop in the second 
decade and increase in number with age9,10.
Odontogenic tumors are also frequent and 
may be the first manifestation of the syndrome, 
occurring in the first decade and in up to 75% of 
the patients9,10. Multiple radiolucent lesions (uni- 
or multiloculated) in the mandible or maxilla are 
frequent in this individuals10. Ectopic calcifications 
of the central nervous system may occur. Guenova 
et al reported a case of incidental finding of lamellar 
calcification of the falx cerebri leading to the 
diagnosis of Gorlin-Goltz Syndrome11.
Skeletal abnormalities are present in up to 70% 
of patients, and bifid, fused or flattened ribs are 
the most common of them, as seen in this patient. 
Up to 31% present vertebrae alterations such as 
spina bifida occulta, kyphoscoliosis, fusion defects, 
hemivertebra, and Sprengel deformity (congenital 
elevation of scapula)2,9. High and wide forehead, 
frontal bossing, and increased head circumference 
(as in this case) may also occur. Enlarged nasal 
bone is common and may be associated with 
ocular hypertelorism9. 
Hypoplastic maxilla or hyperplasia of mandible 
(with variable prognathism) may also be present. 
Other less common abnormalities include ogival 
palate, cleft lip, impactation and agenesis of 
teeth, syndactyly and polydactyly, mesenteric 
cysts, mesenteric, mammary, ovarian and cardiac 
fibroma2,9.
Medulloblastoma presentation (malignant 
posterior fossa tumor) is uncommon, however it is 
important due to its potential risk of life. This tumor 
is present in up to 10% of cases, and diagnosis 
usually occurs by 5 years of age10. 
Table 1: Major and minor criteria for Gorlin-Goltz Syndrome
Major Criteria Minor Criteria
Three or more basal cell carcinoma or one before 
20 years old 
Macrocephaly (adjusted for height)
Histology confirmed odontogenic keratocysts Congenital malformations: cleft palate or lip, frontal 
bossing, hypertelorism, coarse facies
Three or more palm depressions in the hands or feet Skeletal alterations: Sprengel deformity, deformed 
chest, hemivertebra, fused or enlarged vertebrae, 
hand or feet malformations, syndactyly, bone cysts 
in the hands 
Bilamelar calcification of the falx cerebri Sella turcica pontification 
Bifid, fused or flattened ribs Mesenteric, mammary, ovarian or cardiac fibroma
First-degree relative with the syndrome Medulloblastoma 
Gorlin-Goltz Syndrome
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Management of patients includes surveillance 
of the complications related to the syndrome 
and specific treatment of postnatal tumors and 
odontogenic keratocysts. Treatment of most other 
abnormalities consists in cosmetic interventions. 
Frequent dermatologist consultations are 
recommended, especially during puberty. A 
magnetic resonance of the skull should be 
performed every year until 8 years of age to 
exclude medulloblastoma, as well as panoramic 
x-ray of mandible annually after this age. An 
echocardiography is recommended periodically to 
exclude cardiac fibroma. 
Only a small fraction of the basal cell carcinoma 
(BCC) tumors become invasive, rarely leading to 
death by cerebral or pulmonary dissemination. 
The affected patients should avoid ultraviolet light 
exposure and therapeutic ionizing radiation, if 
possible12. 
BCC should be early treated clinically or 
surgically. Topic application of 5% 5-fluorouracil 
(0,1% tretinoin added or not) could be performed 
in superficial lesions13. A surgical approach to 
the growing or invasive lesions include excision, 
curettage or electrical dissection.
Vismodegib, an agent targeting the sonic 
hedgehog pathway, offers a new approach for 
patients with metastatic disease or no longer 
amenable to local therapy, slowing the rate of 
BCC development and reducing tumor burden in 
NBCCS14. Although these findings are promising, 
side effects, such as loss of taste, muscle cramps, 
hair loss, and weight loss limited the use of 
vismodegib. More studies are required in order to 
determine whether vismodegib has the potential 
to truly cure individual BCCs in NBCCS, as well 
as to clarify the optimal treatment regimen for 
vismodegib in this setting.  
Odontogenic keratocystic tumor standard 
treatment is a wide surgical excision and 
curettage with extraction of associated teeth 
by an oral and maxillofacial surgeon or by an 
otorhinolaryngologist15. 
Patients presenting medulloblastoma require 
intensive multimodal therapy. The best results are 
achieved with aggressive resection, chemotherapy, 
and radiation therapy. Radiotherapy may induce 
multiple BCC16 or others intracranial and sinus nasal 
tumors17 in these patients, therefore postoperative 
radiotherapy should be performed judiciously.   
Life expectation for patients with this syndrome 
is not significantly altered, since the most common 
lesions are benign. However, the morbidity of its 
complications could be important, such as the 
medulloblastoma as a potential cause of premature 
death. 
In summary, Gorlin-Goltz Syndrome is a 
dominant autosomal genetic disorder that can lead 
to cancer and other developmental abnormalities. 
Clinical evaluation is key to correct diagnosis, 
leading to early treatment to the affected patients. 
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